Gossamer Bio, Inc. Common Stock (GOSS) is a publicly traded Healthcare sector company. As of October 23, 2026, GOSS trades at $9.44 with a market cap of $59.88M and a P/E ratio of -41.62. GOSS moved -3.58% today. Year to date, GOSS is -95.68%; over the trailing twelve months it is -94.65%. Its 52-week range spans $8.29 to $309.60. Analyst consensus is buy with an average price target of $86.48. Rallies surfaces GOSS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest GOSS news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $9.44 |
| Market Cap | $59.88M |
| P/E Ratio | -41.62 |
| EPS | $-0.25 |
| Dividend Yield | 0.00% |
| 52-Week High | $309.60 |
| 52-Week Low | $8.29 |
| Volume | 168.47K |
| Avg Volume | 0 |
| Revenue (TTM) | $114.70M |
| Net Income | $-56.53M |
| Gross Margin | 0.00% |
6 analysts cover GOSS: 0 strong buy, 3 buy, 2 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $86.48.